CLINICAL TRIALS PROFILE FOR RIMIFON
✉ Email this page to a colleague
All Clinical Trials for RIMIFON
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05534750 ↗ | Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB) | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | Phase 2 | 2022-09-01 | The objective of this work is to measure the early bactericidal activity of tedizolid, to compare it with the bactericidal activity of linezolid (reference molecule for the treatment of multidrug-resistant tuberculosis) and with that of standard quadruple therapy (reference treatment of drug susceptible tuberculosis). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for RIMIFON
Condition Name
Clinical Trial Locations for RIMIFON
Clinical Trial Progress for RIMIFON
Clinical Trial Phase
Clinical Trial Sponsors for RIMIFON
Sponsor Name